EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

One Health genomic surveillance identified high-risk carbapenem-resistant ST821 clones of Acinetobacter baumannii in Nigerian clinical and community settings

Khalifa J Saleh, Oliver McNeilly, Hafsat M Tsangaya, Maryam I Musa, Samantha Palethorpe, Nafisat A Kachalla, Husna F Ibrahim, Jeremy S Brown, Hamisu M Salihu, Richard A Stabler, Ibrahim Yusuf

Microbial Genomics · 29.06.2026 · 12 (6)

DOI: 10.1099/mgen.0.001768 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbial Genomics, erschienen am 29.06.2026. Verfasst von Khalifa J Saleh und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Faculty of Life Sciences, Bayero University Kano, Kano, Nigeria. Hauptthemen laut MEDLINE: Acinetobacter baumannii, Acinetobacter Infections, Carbapenems, Drug Resistance, Multiple, Bacterial. Die Arbeit nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acinetobacter baumannii is a Gram-negative opportunistic pathogen increasingly implicated in severe hospital and community-acquired infections. In Nigeria, widespread antibiotic use across human, animal and environmental sectors contributes to antibiotic selection pressures that drive the emergence and spread of high-risk multidrug-resistant lineages. This One Health genomic surveillance study investigated the prevalence, resistance mechanisms, genomic characteristics and reservoirs of A. baumannii across multiple sources in Kano, Nigeria. A total of 3,235 samples were collected from clinical samples, hospital environments, non-hospital environments and poultry droppings. A. baumannii isolates were identified by growth on MacConkey/CHROMagar and confirmed by bla OXA-51-like amplification. Antimicrobial susceptibility was assessed using the Kirby–Bauer disc diffusion method. Of all samples, 62 isolates were confirmed as A. baumannii , originating from clinical samples ( n =24), hospital environments ( n =33), non-hospital environments ( n =2) and poultry droppings ( n =3). Whole-genome sequencing of 27 select isolates was performed to characterize resistance and virulence genes, sequence types (STs), mobile genetic elements, genomic islands and SNP-based relatedness. Thirteen bla OXA-51-like and one bla OXA-58-like variants were detected. MLST revealed 21 STs using the Pasteur scheme and 14 using the Oxford scheme, many of which were susceptible to most antibiotics tested. In contrast, isolates N9, N13 and N16 (ST821) and N19 (ST625) were resistant to all tested antibiotics, including carbapenems. The highly resistant ST821 clones were isolated from a municipal dumpsite, hospital floors and a hospital bedside surface and separated by only 5–17 SNPs, indicating close relatedness and clonality. Previously reported ST821 strains from the UK, Pakistan, Germany and Nigeria were highly susceptible to antimicrobials. Although no plasmids were detected, complementary genomic islands were identified in N9, N13 and N16 containing bla NDM-1 , tetA/tetR , folP , aac , aphA , dinB , cueR and trxC and therefore likely to confer resistance to antimicrobials. In conclusion, this study provides the first broad One Health genomic overview of A. baumannii circulating across human, environmental and poultry sources in northern Nigeria, revealing substantial genomic diversity and the identification of a closely related extreme drug-resistant ST821 lineage spanning hospital and community environments.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acinetobacter baumanniiAcinetobacter InfectionsCarbapenemsDrug Resistance, Multiple, BacterialNigeriaHumansAnti-Bacterial AgentsMicrobial Sensitivity TestsOne HealthAnimalsWhole Genome Sequencingbeta-LactamasesCommunity-Acquired InfectionsGenome, BacterialMultilocus Sequence Typing

Stichwörter der Autor:innen

Acinetobacter baumanniiMultidrug resistanceNigeriaOne Healthantibiotic resistancegenomic surveillance

Substanzen

CarbapenemsAnti-Bacterial Agentsbeta-Lactamases

Autor:innen und Institutionen

  • Department of Microbiology, Faculty of Life Sciences, Bayero University Kano, Kano, Nigeria.
  • Department of Microbiology, Federal University Dutsin-Ma, Kilometer 60, Along Katsina-Kankara Road, Katsina, Nigeria.
  • Department of Infection Biology, London School of Hygiene and Tropical Medicine, London, UK.
  • Department of Microbiology, Faculty of Life Sciences, Ahmadu Bello University, Zaria, Nigeria.
  • UCL Respiratory, University College London, London, UK.
  • Department of Microbiology, Faculty of Life Sciences, Modibbo Adama University, Yola, Adamawa, Nigeria.

Förderung

  • Medical Research Council

Zitieren

APA

Saleh, K. J., McNeilly, O., Tsangaya, H. M., Musa, M. I., Palethorpe, S., Kachalla, N. A., Ibrahim, H. F., Brown, J. S., Salihu, H. M., Stabler, R. A., & Yusuf, I. (2026). One Health genomic surveillance identified high-risk carbapenem-resistant ST821 clones of Acinetobacter baumannii in Nigerian clinical and community settings. Microbial Genomics, 12(6). https://doi.org/10.1099/mgen.0.001768

Vancouver

Saleh KJ, McNeilly O, Tsangaya HM, Musa MI, Palethorpe S, Kachalla NA, et al. One Health genomic surveillance identified high-risk carbapenem-resistant ST821 clones of Acinetobacter baumannii in Nigerian clinical and community settings. Microbial Genomics. 2026;12(6). doi:10.1099/mgen.0.001768

BibTeX
@article{Saleh2026,
  author = {Saleh, Khalifa J and McNeilly, Oliver and Tsangaya, Hafsat M and Musa, Maryam I and Palethorpe, Samantha and Kachalla, Nafisat A and Ibrahim, Husna F and Brown, Jeremy S and Salihu, Hamisu M and Stabler, Richard A and Yusuf, Ibrahim},
  title = {One Health genomic surveillance identified high-risk carbapenem-resistant ST821 clones of Acinetobacter baumannii in Nigerian clinical and community settings},
  journal = {Microbial Genomics},
  year = {2026},
  volume = {12},
  number = {6},
  doi = {10.1099/mgen.0.001768}
}
Kostenlos starten →